CN109985030A - 醌式查尔酮化合物在制备抗肿瘤药物中的应用 - Google Patents
醌式查尔酮化合物在制备抗肿瘤药物中的应用 Download PDFInfo
- Publication number
- CN109985030A CN109985030A CN201711309136.0A CN201711309136A CN109985030A CN 109985030 A CN109985030 A CN 109985030A CN 201711309136 A CN201711309136 A CN 201711309136A CN 109985030 A CN109985030 A CN 109985030A
- Authority
- CN
- China
- Prior art keywords
- tumor
- cell
- ifn
- drug
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/215—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/217—IFN-gamma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C50/00—Quinones
- C07C50/02—Quinones with monocyclic quinoid structure
- C07C50/06—Quinones with monocyclic quinoid structure with unsaturation outside the quinoid structure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C50/00—Quinones
- C07C50/26—Quinones containing groups having oxygen atoms singly bound to carbon atoms
- C07C50/30—Quinones containing groups having oxygen atoms singly bound to carbon atoms with polycyclic non-condensed quinoid structure
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (18)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711309136.0A CN109985030B (zh) | 2017-12-11 | 2017-12-11 | 醌式查尔酮化合物在制备抗肿瘤药物中的应用 |
EP18889684.9A EP3675841B1 (en) | 2017-12-11 | 2018-02-02 | A novel quinochalcone compound and uses thereof for treating cancer or inflammation |
JP2020552072A JP6987271B2 (ja) | 2017-12-11 | 2018-02-02 | 新規キノカルコン化合物、及びがん又は炎症を治療するためのその用途 |
PCT/CN2018/075163 WO2019114125A1 (en) | 2017-12-11 | 2018-02-02 | A novel quinochalcone compound and uses thereof for treating cancer or inflammation |
US16/897,733 US10988429B2 (en) | 2017-12-11 | 2020-06-10 | Quinochalcone compound and uses thereof for treating cancer or inflammation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711309136.0A CN109985030B (zh) | 2017-12-11 | 2017-12-11 | 醌式查尔酮化合物在制备抗肿瘤药物中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109985030A true CN109985030A (zh) | 2019-07-09 |
CN109985030B CN109985030B (zh) | 2021-07-06 |
Family
ID=66819884
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711309136.0A Active CN109985030B (zh) | 2017-12-11 | 2017-12-11 | 醌式查尔酮化合物在制备抗肿瘤药物中的应用 |
Country Status (5)
Country | Link |
---|---|
US (1) | US10988429B2 (zh) |
EP (1) | EP3675841B1 (zh) |
JP (1) | JP6987271B2 (zh) |
CN (1) | CN109985030B (zh) |
WO (1) | WO2019114125A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114409522A (zh) * | 2022-03-01 | 2022-04-29 | 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) | 一种查尔酮衍生物及其制备方法与用途 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105085219A (zh) * | 2014-05-22 | 2015-11-25 | 中国医学科学院药物研究所 | A环具有异戊烯基的醌式查尔酮化合物,制法与抗炎活性 |
CN105085218A (zh) * | 2014-05-22 | 2015-11-25 | 中国医学科学院药物研究所 | 一类a环具有甲基的醌式查尔酮化合物,制法与抗炎活性 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013054998A1 (ko) * | 2011-10-13 | 2013-04-18 | 건국대학교 산학협력단 | 신규한 칼콘 유도체 및 이를 유효성분으로 하는 항암제 조성물 |
-
2017
- 2017-12-11 CN CN201711309136.0A patent/CN109985030B/zh active Active
-
2018
- 2018-02-02 WO PCT/CN2018/075163 patent/WO2019114125A1/en unknown
- 2018-02-02 JP JP2020552072A patent/JP6987271B2/ja active Active
- 2018-02-02 EP EP18889684.9A patent/EP3675841B1/en active Active
-
2020
- 2020-06-10 US US16/897,733 patent/US10988429B2/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105085219A (zh) * | 2014-05-22 | 2015-11-25 | 中国医学科学院药物研究所 | A环具有异戊烯基的醌式查尔酮化合物,制法与抗炎活性 |
CN105085218A (zh) * | 2014-05-22 | 2015-11-25 | 中国医学科学院药物研究所 | 一类a环具有甲基的醌式查尔酮化合物,制法与抗炎活性 |
Non-Patent Citations (4)
Title |
---|
KYOKO NAKAGAWA-GOTO等: "Antitumor Agents 259. Design, Syntheses, and Structure-Activity Relationship Study of Desmosdumotin C Analogs", 《JOURNAL OF MEDICINAL CHEMISTRY》 * |
KYOKO NAKAGAWA-GOTO等: "Antitumor agents 283. Further elaboration of Desmosdumotin C analogs as potent antitumor agents: Activation of spindle assembly checkpoint as possible mode of action", 《BIOORGANIC & MEDICINAL CHEMISTRY》 * |
向卓等: "毛叶假鹰爪素C 衍生物的合成、构效关系分析及其抗肿瘤活性研究", 《中国药学杂志》 * |
苑振亭等: "《临床用药指南与评价》", 31 August 2016, 金盾出版社 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114409522A (zh) * | 2022-03-01 | 2022-04-29 | 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) | 一种查尔酮衍生物及其制备方法与用途 |
CN114409522B (zh) * | 2022-03-01 | 2023-08-15 | 贵州省天然产物研究中心 | 一种查尔酮衍生物及其制备方法与用途 |
Also Published As
Publication number | Publication date |
---|---|
EP3675841B1 (en) | 2024-04-10 |
US10988429B2 (en) | 2021-04-27 |
WO2019114125A1 (en) | 2019-06-20 |
US20200377439A1 (en) | 2020-12-03 |
JP6987271B2 (ja) | 2021-12-22 |
CN109985030B (zh) | 2021-07-06 |
EP3675841A1 (en) | 2020-07-08 |
EP3675841A4 (en) | 2021-06-09 |
JP2021505691A (ja) | 2021-02-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104739888A (zh) | 冠突散囊菌菌粉及其制备方法和应用 | |
CN108159038A (zh) | 一种药物组合物及其在制备治疗肿瘤多药耐药性的药物中的用途 | |
CN106822905A (zh) | 含Survivin抑制剂和IRE1抑制剂的药物及用途 | |
EP0774255B1 (en) | Use of ursolic acid for the manufacture of a medicament for suppressing metastasis | |
US20220133675A1 (en) | Phorbol ester compositions and methods of use for treating or reducing the duration of cytopenia | |
US20210353580A1 (en) | Application of chlorogenic acid and compositions thereof in preparation of drugs for treating squamous cell carcinoma | |
CN102688493B (zh) | 含有白藜芦醇及白藜芦醇类衍生物和Bc1-2抑制剂的药物组合物及其应用 | |
CN109985030A (zh) | 醌式查尔酮化合物在制备抗肿瘤药物中的应用 | |
CN101062041B (zh) | 葫芦素新的医药用途 | |
CN104337823B (zh) | 一种抑制肿瘤的药物组合物 | |
CN116726021A (zh) | 一种drp1抑制剂和铁死亡诱导剂联合用药物及其抗肿瘤的用途 | |
Valadares et al. | The effect of a titanocene dichloride derivative, Ti IV (C5H5) 2 NCS2, on the haematopoietic response of Ehrlich tumour-bearing mice | |
CN114522158B (zh) | 用于制备治疗肝癌药物的代谢物及其应用 | |
CN109793727A (zh) | 一种有效抗恶性肿瘤的药物组合物及其应用 | |
CN105535003A (zh) | 金盏花苷e在制备治疗抗肿瘤药物中的用途 | |
WO2021023291A1 (zh) | 原黄素在肺癌治疗中的应用 | |
CN111375048A (zh) | 脾氨肽在制备治疗白细胞减少症的药物中的应用 | |
CN106075454A (zh) | 一种抗肿瘤药物制剂组合 | |
WO2021023290A1 (zh) | 吡硫锌在肺癌治疗中的应用 | |
CN111249274B (zh) | 银杏内酯b在制备胶质瘤细胞活性抑制剂中的应用 | |
CN111803484B (zh) | 奥替溴铵在制备抗肿瘤药物中的应用 | |
CN108853506A (zh) | 一种治疗白血病的联用药物及其用途 | |
CN109966275A (zh) | 醌式查尔酮化合物在制备抗肿瘤药物中的应用 | |
CN109331026A (zh) | 替加环素在制备抗多发性骨髓瘤药物中的应用 | |
TWI635867B (zh) | 中草藥組合物製備抑制腫瘤細胞轉移之藥物之用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20200826 Address after: Room B307, building 1, No. 29, life Garden Road, Huilongguan town, Changping District, Beijing 100096 (Changping Demonstration Park) Applicant after: Guchong Pharmaceutical (Beijing) Co.,Ltd. Address before: 101400 Beijing Huairou North Fang Yuhua Garden Area 2-1-1401 Applicant before: LIFE-GARDEN BIOTECH |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: Room 609, No. 6 North Row, No. 28 Courtyard, Dongbeiwang Village South, Dongbeiwang Township, Haidian District, Beijing, 100193 Patentee after: Guchong Pharmaceutical (Beijing) Co.,Ltd. Address before: 100096 room B307, building 1, 29 shengshengyuan Road, Huilongguan town, Changping District, Beijing (Changping Demonstration Park) Patentee before: Guchong Pharmaceutical (Beijing) Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230504 Address after: Room 176, 1st Floor, Building B, Entrepreneurship Development Center, No. 12 Yushun Road, Yufa Town, Daxing District, Beijing 102600 (cluster registration) Patentee after: Jichong (Beijing) Pharmaceutical Co.,Ltd. Address before: Room 609, No. 6 North Row, No. 28 Courtyard, Dongbeiwang Village South, Dongbeiwang Township, Haidian District, Beijing, 100193 Patentee before: Guchong Pharmaceutical (Beijing) Co.,Ltd. |